期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 53, 期 7, 页码 2766-2778出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm901860h
关键词
-
资金
- National Institutes of Health [R01 GM067958, T32 GM008715, HL081682, GM50388]
- American Heart Association
Sphingosine 1-phosphate (S1P), a potent phospholipid growth and trophic factor, is synthesized in vivo by two sphingosine kinases. Thus these kinases have been proposed as important drug targets for treatment of hyperproliferative diseases and inflammation. We report here a new class of amidine-based sphingosine analogues that are competitive inhibitors of sphingosine kinases exhibiting varying degrees of enzyme selectivity. These inhibitors display K(I) values in the submicromolar range for both sphingosine kinases and, in cultured vascular smooth muscle cells, decrease S1P levels and initiate growth arrest.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据